Insider · CIK 0001202090

DUYK GEOFFREY M

Reports to the SEC for 5 companies · FORT WORTH, TX

sec.gov

Transactions

Companies

Filings

CIK

0001202090

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-05-07	AMYRIS, INC.J Other	Director	JOther	−40.6K sh	—	—	0
2023-01-03	AMYRIS, INC.G Gift	Director	GGift	−2,437 sh	—	—	80,000
2023-01-03	AMYRIS, INC.G Gift	Director	GGift	+2,437 sh	—	—	40,552
2022-09-30	AMYRIS, INC.G Gift	Director	GGift	−2,436 sh	—	—	82,437
2022-09-30	AMYRIS, INC.G Gift	Director	GGift	+2,436 sh	—	—	38,115
2022-08-23	AMYRIS, INC.G Gift	Director	GGift	−7,409 sh	—	—	82,437
2022-08-23	AMYRIS, INC.G Gift	Director	GGift	+7,409 sh	—	—	38,115
2022-08-22	AMYRIS, INC.A Award	Director	AAward	+80K sh	—	—	97,154
2022-06-30	AMYRIS, INC.G Gift	Director	GGift	+2,436 sh	—	—	38,115
2022-06-30	AMYRIS, INC.G Gift	Director	GGift	−2,436 sh	—	—	82,437
2022-03-31	AMYRIS, INC.G Gift	Director	GGift	+2,436 sh	—	—	38,115
2022-03-31	AMYRIS, INC.G Gift	Director	GGift	−2,436 sh	—	—	82,437
2022-01-18	AMYRIS, INC.A Award	Director	AAward	+9,745 sh	—	—	40,552
2021-08-23	AMYRIS, INC.A Award	Director	AAward	+7,409 sh	—	—	30,807
2021-08-09	AMYRIS, INC.G Gift	Director	GGift	+9,566 sh	—	—	9,566
2021-08-09	AMYRIS, INC.G Gift	Director	GGift	−9,566 sh	—	—	30,986
2020-11-02	AMYRIS, INC.G Gift	Director	GGift	+13.8K sh	—	—	23,398
2020-11-02	AMYRIS, INC.G Gift	Director	GGift	−13.8K sh	—	—	17,154
2020-08-05	AMYRIS, INC.Warrant (Right to Buy)A Award	Director	AAward	+3,466 sh	—	—	3,466
2020-08-05	AMYRIS, INC.A Award	Director	AAward	+9,566 sh	—	—	23,398
2019-10-23	AMYRIS, INC.Stock Option (Right to Buy)A Award	Director	AAward	+3,466 sh	—	—	3,466
2019-10-23	AMYRIS, INC.A Award	Director	AAward	+9,566 sh	—	—	13,832
2017-02-15	AERIE PHARMACEUTICALS INCS Sale	Director	SSale	−20.8K sh	$46.81	−$973K	3,400
2017-02-14	AERIE PHARMACEUTICALS INCF Tax Payment	Director	FTax Payment	−1,879 sh	$46.95	−$88.2K	44,991
2017-02-14	AERIE PHARMACEUTICALS INCStock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−28K sh	—	—	0
2017-02-14	AERIE PHARMACEUTICALS INCStock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−13.5K sh	—	—	0
2017-02-14	AERIE PHARMACEUTICALS INCStock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2017-02-14	AERIE PHARMACEUTICALS INCStock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,667 sh	—	—	3,333
2017-02-14	AERIE PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+6,667 sh	$19.50	+$130K	10,067
2017-02-14	AERIE PHARMACEUTICALS INCF Tax Payment	Director	FTax Payment	−2,770 sh	$46.95	−$130K	7,297
2017-02-14	AERIE PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$32.30	+$323K	17,297
2017-02-14	AERIE PHARMACEUTICALS INCF Tax Payment	Director	FTax Payment	−6,880 sh	$46.95	−$323K	10,417
2017-02-14	AERIE PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+13.5K sh	$17.55	+$237K	23,917
2017-02-14	AERIE PHARMACEUTICALS INCF Tax Payment	Director	FTax Payment	−5,047 sh	$46.95	−$237K	18,870
2017-02-14	AERIE PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+28K sh	$3.15	+$88.2K	46,870
2017-02-14	AERIE PHARMACEUTICALS INCS Sale	Director	SSale	−20.8K sh	$46.46	−$966K	24,196
2016-11-03	AMYRIS, INC.A Award	Director	AAward	+35K sh	—	—	64,000
2016-07-13	AMYRIS, INC.Stock Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,000
2016-07-13	AMYRIS, INC.A Award	Director	AAward	+17K sh	—	—	29,000
2016-06-08	AERIE PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2016-06-08	AERIE PHARMACEUTICALS INCA Award	Director	AAward	+1,700 sh	—	—	3,400
2015-07-30	AMYRIS, INC.A Award	Director	AAward	+3,000 sh	—	—	12,000
2015-07-30	AMYRIS, INC.Stock Option (Right to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2015-06-05	EPIRUS Biopharmaceuticals, Inc.Non-Employee Stock Option (Right to Buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2015-04-10	AERIE PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2015-04-10	AERIE PHARMACEUTICALS INCA Award	Director	AAward	+1,700 sh	—	—	1,700
2014-08-06	AMYRIS, INC.A Award	Director	AAward	+3,000 sh	—	—	9,000
2014-08-06	AMYRIS, INC.Stock Option (Right to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2013-08-01	AMYRIS, INC.Stock Option (Right to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2013-08-01	AMYRIS, INC.A Award	Director	AAward	+3,000 sh	—	—	6,000

Recent filings

Accepted (ET)
May 74
DUYK GEOFFREY M0001415889-24-012559
SEC(opens sec.gov)
Feb 145
DUYK GEOFFREY M0001365916-23-000011
SEC(opens sec.gov)
Feb 144
DUYK GEOFFREY M0001365916-23-000012
SEC(opens sec.gov)
Aug 244
DUYK GEOFFREY M0001365916-22-000105
SEC(opens sec.gov)
Feb 115
DUYK GEOFFREY M0001365916-22-000025
SEC(opens sec.gov)
Jan 204
DUYK GEOFFREY M0001365916-22-000015
SEC(opens sec.gov)
Aug 254
DUYK GEOFFREY M0001365916-21-000081
SEC(opens sec.gov)
Aug 74
DUYK GEOFFREY M0001365916-20-000143
SEC(opens sec.gov)

Companies

Address

TPG CAPITAL, L.P. 301 COMMERCE STREET, SUITE 3300

FORT WORTH, TX, 76102